January 2, 2013
In our era of instant gratification, the world of medicine seems like an outlier. The path from a promising discovery to an effective treatment often takes a decade or more…After years of controversy, gene therapy is poised to become a viable option for a variety of often life-threatening medical conditions, especially those resulting from a […]
Tags: blindness, defective gene, gene therapy, Glybera, heart failure, hemophelia, molecular medicine, Stephen J. Russell, Wall Street Journal